Britannia Life Sciences Inc. (BLAB.CN)
Britannia Life Sciences Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.07, down 0.00% on the session, giving a market capitalisation of $10.5M. Its beta of -0.06 implies it has historically moved less than the broad market.
Britannia Life Sciences Inc., headquartered in Toronto, Canada, offers specialized services in rigorous product evaluation, comprehensive safety analysis, and adherence to regulatory standards. The company supports businesses within the cosmetics, nutraceutical, and consumer packaged goods (CPG) sectors, operating extensively throughout the United Kingdom and various international markets.
Britannia Life Sciences Inc. is most often compared with the following Healthcare names: